Education
Health
Dr. Jagdish Sakhiya Launches Anti Acne Kit for Oily and Acne Prone Skin
A 4-step skincare routine based on 27 years of dermatology experience is now available for home use
Surat (Gujarat) [India], December 30: Dr. Sakhiya’s Anti-Acne and Pimple Care Kit was officially launched at Sakhiya Skin Clinic, Lal Darwaja, Surat. The kit has been scientifically developed especially for Indian oily and acne-prone skin. It is a dermatologist-designed 4-step skincare routine that makes it possible to follow clinic-level acne treatment at home in a simple and safe way.
On this occasion, Dr. Jagdish Sakhiya, Founder of Sakhiya Skin Clinic and a well-known dermatologist, said that the problem of acne and pimples is increasing rapidly among teenagers, youth, and working professionals. He added that incorrect or unscientific products available in the market often damage the skin instead of improving it. Based on his 27 years of clinical experience, this kit has been developed specifically for Indian skin, keeping it safe, effective, and scientifically proven.
Four-Step Dermatologist-Designed Routine
Dr. Sakhiya’s Anti-Acne and Pimple Care Kit includes four essential steps:
-
A face wash that controls excess oil and deeply cleanses pores
-
An A.M. cream that reduces active acne and prevents new breakouts
-
A mild, non-comedogenic sunscreen that protects against acne marks and pigmentation
-
A night cream that works on acne from the root and gradually lightens acne marks
The kit contains dermatologist-trusted ingredients such as Salicylic Acid, Niacinamide, Azelaic Acid, Zinc PCA, and Hyaluronic Acid, which help maintain healthy and clear skin over the long term.
Dr. Sakhiya further explained that people often need to buy multiple products—face washes, serums, creams, sunscreens, and night treatments—from different brands to manage acne, making the routine confusing and expensive. To address this issue, all dermatologist-recommended steps have been combined into a single, convenient box.
This launch marks an important step toward making dermatologist-level acne treatment easier, more effective, and more affordable, while also spreading awareness about the right approach to skincare.
Business
नए साल का पहला दिन: Indian Tobacco Stocks Fall as Government Lights Up New Tax
New Delhi [India], January 1: New year optimism lasted exactly one session. Indian tobacco stocks fall after the government quietly rewired cigarette taxes and markets reacted, fast and without mercy.
Indian tobacco stocks fall was the story traders could not ignore on Thursday. Screens lit up red. Orders thinned. And by mid-session, it was obvious this was not a mood swing. It was policy colliding with profit.
The finance ministry late Wednesday notified a new excise duty on cigarettes, effective February 1. No drama. No long speech. Just numbers. And those numbers hurt.
Market leader ITC slipped 4.4 percent. The stock traded at 385.25 rupees, a level not seen since June 2024. Worse, it marked ITC’s sharpest single-day drop since February 2022. For a stock often treated like a bond with dividends, that stung.
Godfrey Phillips India took a harder punch. Shares of the Marlboro distributor sank 7.7 percent. Investors did not wait around for management commentary. They sold first. Questions can come later.
ITC ended up as the biggest loser on the Nifty 50. It also dragged the FMCG index lower, down 1.6 percent on the day. When ITC moves, the index does not argue.
Indian Tobacco Stocks: So what changed overnight?
The government imposed an excise duty ranging from 2,050 rupees to 8,500 rupees per 1,000 cigarette sticks, depending on length. In plain terms, longer cigarettes now cost a lot more to make and sell. The levy comes on top of the existing 40 percent Goods and Services Tax. Yes, on top. Not instead.
Analysts at ICICI Securities did the math quickly. The duty implies a 22 percent to 28 percent increase in overall costs for cigarettes sized between 75 and 85 millimetres. That is not a rounding error. That is a margin conversation.
Cigarettes longer than 75 millimetres make up roughly 16 percent of ITC’s volumes. Those sticks could see price hikes of 2 to 3 rupees per cigarette. Per stick. Pause there for a second. In India, that matters.
The government has not spelt out how much of this tax will be passed on to consumers. It rarely does. But markets are not naïve. Higher taxes usually mean higher prices, eventually. Companies can cushion the blow only so much before profitability starts to creak.
This tax move follows December’s approval of the Central Excise (Amendment) Bill 2025. That bill replaces a temporary levy on cigarettes and tobacco products with a more permanent framework. Translation, again. This is not a trial balloon. It is a structural shift.
Why the persistence?
Health, for one. Smoking-related diseases continue to drain India’s healthcare system. The government has leaned on multiple levers over the years. Bigger warning labels. Advertising curbs. Periodic tax hikes. The message is consistent, even if the execution feels abrupt.
India has an estimated 100 million smokers. That scale makes tobacco both a public health problem and a revenue machine. Raise taxes, discourage consumption, collect more money. The theory holds. Reality, as always, is messier.
Markets live in that mess. Indian tobacco stocks fall because investors see second-order effects. Volume pressure. Downtrading. The quiet return of illicit cigarettes. None of these show up in the notification. All of them show up in valuations.
ITC sits in a particularly awkward spot. Cigarettes still bankroll its ambitions elsewhere, from packaged foods to hotels. Every tax hike chips away at that cash engine. Diversification helps, sure. It does not erase dependence.
There is also history to consider. Sharp price hikes have previously nudged consumers toward unregulated products. That hurts legitimate players and, ironically, tax collections too. Policy makers know this. The market remembers it.
For now, the reaction is blunt. Indian tobacco stocks fall because certainty vanished overnight. Investors will now watch pricing decisions, distributor feedback, and early volume signals once February arrives.
Until then, the message is clear. The government has moved its piece. The industry must respond. And the market will keep score.
